-
Prochlorperazine: Bench-to-Protocol Research Guide
2026-08-21
Prochlorperazine connects dopamine D2 receptor pharmacology with practical workflows in melanoma research, antiviral screening, and antiemetic therapy. This guide translates its concentration-dependent cellular effects and an acute mountain sickness trial protocol into assay design, controls, and troubleshooting decisions.
-
DAPT (GSI-IX): From Pathway Tool to Translation
2026-08-20
A translational framework for using DAPT (GSI-IX) to connect γ-secretase biology, Notch signaling, epithelial cell fate, and disease-model decision-making.
-
NAD+ Workflows for Metabolic Stress Assays
2026-08-20
Use NAD+ as a controlled redox and enzyme-substrate variable when dissecting energy stress, autophagy, DNA damage signaling, and protein deacetylation. This guide translates the latest AMPK–ULK1 findings into practical assay matrices, sample-handling controls, and troubleshooting decisions without treating NAD+ as a universal autophagy activator.
-
AI-10-49: CBFβ-SMMHC Inhibitor Evidence
2026-08-19
AI-10-49 is a selective CBFβ-SMMHC inhibitor that disrupts the leukemia-associated fusion protein interaction with RUNX1. Reported cellular, chromatin, and mouse-model findings support its use in acute myeloid leukemia research, while product specifications define its formulation and storage boundaries.
-
Full-Length αvβ3 Integrin Cryo-EM Conformations
2026-08-19
This cryo-EM study maps full-length human αvβ3 integrin across six apo and five ligand-bound conformations, including five previously uncharacterized states. The resulting continuum model clarifies how inhibitors engage distinct receptor states and provides a structural basis for designing more selective integrin-targeted compounds.
-
SP2509: An Epigenetic Decision Framework for AML
2026-08-18
SP2509 is a Lysine-specific demethylase 1 antagonist that links LSD1 inhibition to chromatin, differentiation, and apoptosis readouts in acute myeloid leukemia research. This article presents a decision-oriented assay framework and explains how cross-cancer epigenetic evidence can improve experimental design without overstating translation.
-
Dacomitinib in Cancer Signaling Workflows
2026-08-18
Dacomitinib (PF-00299804) enables controlled studies of irreversible ErbB signaling blockade, sustained pathway suppression, cell-cycle effects, and apoptosis in resistant cancer models. This workflow-focused guide also shows how to evaluate a hypothesis linking pan-HER inhibition with METTL17-associated mitochondrial ferroptosis defenses without overstating evidence from colorectal cancer research.
-
L-Phenylephrine in α1A Signaling Workflows
2026-08-17
Build more interpretable cardiovascular, cardiomyocyte, and neural assays with L-Phenylephrine, an adrenergic α1A receptor agonist suited to controlled receptor-stimulation experiments. This guide connects receptor-selective workflows with sex-aware hypertension research while emphasizing controls, timing, solution stability, and translational limits.
-
Sulfo-Cy5 NHS Ester for Immune Assay Design
2026-08-17
Sulfo-Cy5 NHS ester enables aqueous amine labeling with far-red sensitivity and reduced dye–dye quenching. This article presents an assay-design framework linking fluorescent readouts to the immune-mechanistic findings of a metal-ion-chelating nanostructure study.
-
THBS1 in Laryngeal Cancer: Prognostic Insights
2026-08-16
An integrative study combined transcriptomic datasets, machine learning, survival analysis, immune-pathway profiling, and cell-based assays to identify THBS1 as a prognostic biomarker and potential therapeutic vulnerability in laryngeal cancer. The findings connect THBS1 expression with epithelial-to-mesenchymal transition, integrin signaling, lipid metabolism, immune suppression, and aggressive cellular behavior, while also highlighting the need for prospective validation.
-
Influenza Hemagglutinin (HA) Peptide Workflow Guide
2026-08-15
Build cleaner HA-tagged protein capture, competitive elution, and interaction studies with a high-purity nine-residue reagent. This workflow guide connects practical Anti-HA immunoprecipitation optimization with a recent IDH1 cancer-mechanism study, while separating established assay utility from emerging biological interpretation.
-
Kanamycin Sulfate: Practical Microbiology Workflows
2026-08-14
Learn how to use Kanamycin Sulfate for bacterial selection, broth microdilution, and antibiotic resistance research. The workflow combines product-handling guidance with comparative lessons from a 565-isolate aminoglycoside study, helping researchers improve assay consistency without overinterpreting historical susceptibility data.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-14
A 2024 Cellular & Molecular Immunology study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing in activated CD8+ T cells. By favoring PKM2 over PKM1 independently of the canonical CD28–PI3K pathway, this mechanism links RNA processing to metabolic flexibility, interferon-γ production, and antitumor immunity.
-
Trichostatin A (TSA): A Translational Playbook
2026-08-13
Trichostatin A (TSA) is more than a histone deacetylase inhibitor: it is a reversible perturbation tool for connecting chromatin state, tumor-cell behavior, combination response, and in vivo validation. This thought-leadership guide explains how to use TSA strategically in cancer research, with emphasis on epigenetic regulation in cancer, cell-cycle control, and translational decision-making.
-
DDM for Cryo-EM Membrane Protein Assays
2026-08-13
Discover how n-Dodecyl-β-D-maltoside and DDM can be treated as assay-design variables rather than generic extraction reagents. This guide connects detergent chemistry with cryo-EM analysis of dynamic membrane protein complexes, including full-length αvβ3 integrin.